Press Releases

Press Releases

07.13.17
OpGen Announces Pricing of $10.0 Million Public Offering
07.12.17
OpGen Acuitas® MDRO Gene Test Approved by NY State Department of Health
06.19.17
OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid Test
06.15.17
OpGen’s Acuitas® Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities
06.05.17
OpGen Data at ASM Microbe 2017 Demonstrates Potential of Acuitas Products for Predicting Antibiotic Susceptibility and Infection Control
05.30.17
OpGen to Receive Ignaz Semmelweis Award for Commitment to Combatting Infection Deaths
05.25.17
OpGen to Present Advancements in Antibiotic Susceptibility and Whole Genome Sequencing at ASM Microbe 2017
04.27.17
OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors
04.26.17
OpGen Announces 2017 First Quarter Financial Results
04.25.17
OpGen Highlights Capabilities of its Acuitas® Technologies to Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles at ECCMID